AbbVie (Abbott)
Abbott Laboratories is a global pharmaceuticals and health care products company which has a broad range of medical devices, diagnostics and immunoassay products. The company headquarters are in Abbott Park, North Chicago, Illinois. In 2013 Abbott separated into two independent companies: Abbott and AbbVie.
- Aluvia* (lopinavir/ritonavir)
- Kaletra** (lopinavir/ritonavir)
- Norvir (ritonavir)
*Trade name for low-income countries;
**Trade name for high-income countries
Information about the drug products is obtained from public sources or from company representatives and is intended solely for informing community representatives about the options currently available or in development. This information can under no circumstances be intepreted as advertising. The mentioning of any drug products does not mean EECA CAB prioritizes those products or, on the contrary, does not recommend them.
Hepatitis C pipeline
- Non-nucleoside polymerase inhibitors
- ABT-333, twice a day, phase III
- Inhibitors of NS5A
- ABT-267, once a day, phase III
- Protease inhibitors
- ABT-450/r, once a day, phase III
- Fixed-dose combinations
- ABT-267/ABT-450/r, once a day, phase III
Will be available soon.
